search
Back to results

Mobilisation in the EveNing to TreAt Delirium (MENTAL)

Primary Purpose

Critical Illness, Sleep Disturbance, Mobility Limitation

Status
Completed
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Evening mobilisation
Sponsored by
University Hospitals Coventry and Warwickshire NHS Trust
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Critical Illness focused on measuring delirium, non-pharmacological, mobilisation, sleep, intensive care, ICU

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Adults (≥18 years)
  • Admitted to ICU,
  • Able to respond to verbal stimulus (Richmond Agitation Sedation Scale ≥ -3)
  • Expected to stay in the ICU for at least 24 hours.

Exclusion Criteria:

  • Death expected within the next 72 hours,
  • Immobility prior to admission,
  • Mobilisation contraindicated (e.g., spinal injury),
  • Delirium diagnosis during this ICU admission,
  • Acute or subacute severe neurological deficit or injury;
  • Severe psychiatric illness (not including depression) or developmental problems;
  • Suspected or confirmed drug or alcohol intoxication/overdose or withdrawal.

Sites / Locations

  • University Hospitals Coventry & Warwickshire
  • Oxford University Hospitals NHS Foundation Trust

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Intervention

Control

Arm Description

Evening mobilisation delivered between 7pm and 9pm

Patients in the control arm will receive standard care which incorporates physiotherapy and mobilisation as appropriate between 8am and 5pm

Outcomes

Primary Outcome Measures

Recruitment rate
Proportion of patients agreeing to take part out of all those invited
Retention rate
Proportion of participants who complete the intervention
Intervention fidelity
Percentage of intervention sessions completed

Secondary Outcome Measures

Incidence of delirium
Incidence of delirium assessed as a positive result on the CAM-ICU
Duration of delirium
counted at 12-hour periods; the end of delirium is defined when patients are delirium-negative for 24h or discharged to the ward
Sleep quality
as an average and assessed over time using the Richard Campbell Sleep Questionnaire. This provides a score from 0 - 60, with higher scores representing better quality of sleep
Mobility level at critical care discharge
Assessed using the Manchester mobility score. Scores range from 1-7 with higher scores representing higher levels of mobility

Full Information

First Posted
May 23, 2022
Last Updated
May 31, 2023
Sponsor
University Hospitals Coventry and Warwickshire NHS Trust
Collaborators
Oxford University Hospitals NHS Trust, University Hospital Schleswig-Holstein
search

1. Study Identification

Unique Protocol Identification Number
NCT05401461
Brief Title
Mobilisation in the EveNing to TreAt Delirium
Acronym
MENTAL
Official Title
Does Mobilisation in the Evening Reduce the Incidence of Delirium in Patients Admitted to Intensive Care: a Mixed-methods, Randomised Controlled Feasibility Study
Study Type
Interventional

2. Study Status

Record Verification Date
May 2023
Overall Recruitment Status
Completed
Study Start Date
July 1, 2022 (Actual)
Primary Completion Date
October 31, 2022 (Actual)
Study Completion Date
November 30, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospitals Coventry and Warwickshire NHS Trust
Collaborators
Oxford University Hospitals NHS Trust, University Hospital Schleswig-Holstein

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Patients with severe illness require lifesaving treatment in intensive care units. Around a third of patients admitted to intensive care develop delirium. This is a severe state of confusion. Delirium can be a frightening experience. Patients suffering from delirium can find it difficult to think clearly or understand what is happening. In some cases delirium can cause people to see or hear things that are not really there. Patients who develop delirium tend to spend longer in hospital and have worse overall outcomes. A major cause for the development of delirium is poor sleep. Previous research suggests that delirium levels can be reduced when patients are more active. The investigators have noticed that when patients in intensive care have physiotherapy during the day, they are often very tired and fall asleep quickly afterwards. The investigators think that patients who have physiotherapy in the evening will sleep better overnight and hope this will subsequently reduce the number who develop delirium. To answer this question the investigators need to compare patients who are active in the evening with those who only have physiotherapy sessions during the day. Before a full study can take place it is important to make sure it is designed in the best way. To do this, 60 patients will be recruited from 2 hospitals in the UK over 6 months. Half of those who agree to take part will be seen by the physiotherapist in the evening, the other half will not. The investigators will then ask the following questions before deciding whether to do a full study Will patients agree to be a part of this trial? Will they agree to the additional physiotherapy sessions offered in the evening? Will patients and staff members be happy for us to randomly select who receives this extra treatment?
Detailed Description
The investigators hypothesise that mobilisation in the evening will promote more natural sleep, with patients becoming tired from physical exertion and plan to evaluate the impact this may have on reducing the incidence or duration of delirium. A mixed-methods, two centre, randomised controlled feasibility study to establish the viability of conducting a larger multicentre RCT to test the effects of evening mobilisation on the incidence of ICU-acquired delirium. Part 1 will evaluate whether it is possible to achieve acceptable recruitment and retention rates, intervention fidelity, and if the proposed data collection methods are appropriate. Part 2 includes an acceptability analysis and qualitative evaluation, aiming to explore both patient and staff subjective experiences of the study intervention and proposed research methods (including willingness for randomisation and study outcome measures) and provide information to refine the study intervention (if required). The investigators will use principles of Normalisation Process Theory [28] and the NoMAD assessment tool [29] to assess the practicalities associated with implementing additional evening physiotherapy. Treatment / Intervention The intervention will be delivered by a dedicated mobilisation team recruited from the study centres and will include trained ICU physiotherapists. Mobilisation will be delivered according to standardised procedures and established safety criteria. The intervention will begin on day 1 of admission or the first evening following recruitment. After consultation with the responsible physician and nurse, patients will be approached between 19.00 and 21:00 to confirm suitability and consent to mobilise. Patients who are asleep will not be woken for the intervention. Mobilisation will be defined as a score of ≥ 2 on the Manchester mobility score (sit on the edge of the bed or higher), with actual mobilisation level achieved and duration of intervention based on clinical decision of the mobilisation therapists. Patients will also be offered the opportunity to engage in activities which may be part of their normal evening routines (e.g. brushing teeth, reading or watching television). The intervention will be carried out for up to seven consecutive evenings. The intervention will be terminated if a) patient condition deteriorates irretrievably and physiotherapy is no longer appropriate, b) after seven evenings, or c) when the patient is discharged from the ICU. The intervention will not continue at secondary wards or units. The evening mobilisation will be delivered in addition to any input from the MDT during normal daily working hours and will not replace any standard therapy.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Critical Illness, Sleep Disturbance, Mobility Limitation, Intensive Care Unit Delirium
Keywords
delirium, non-pharmacological, mobilisation, sleep, intensive care, ICU

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Mixed methods, randomised controlled feasibility study
Masking
InvestigatorOutcomes Assessor
Masking Description
All outcomes will be collected by an independent researcher blinded to group allocation
Allocation
Randomized
Enrollment
58 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Intervention
Arm Type
Experimental
Arm Description
Evening mobilisation delivered between 7pm and 9pm
Arm Title
Control
Arm Type
No Intervention
Arm Description
Patients in the control arm will receive standard care which incorporates physiotherapy and mobilisation as appropriate between 8am and 5pm
Intervention Type
Other
Intervention Name(s)
Evening mobilisation
Intervention Description
Evening mobilisation delivered between (19.00 and 21.00) according to standardised procedures and established safety criteria. The intervention will begin on day 1 of admission or the first evening following recruitment. Mobilisation will be defined as a score of ≥ 2 on the Manchester mobility score (sit on the edge of the bed or higher), with actual mobilisation level achieved and duration of intervention based on clinical decision of the mobilisation therapists. Patients will also be offered the opportunity to engage in activities which may be part of their normal evening routines (e.g. brushing teeth, reading or watching television). The intervention will be carried out for up to seven consecutive evenings. The evening mobilisation will be delivered in addition to any input from the MDT during normal daily working hours and will not replace any standard therapy.
Primary Outcome Measure Information:
Title
Recruitment rate
Description
Proportion of patients agreeing to take part out of all those invited
Time Frame
3 month recruitment window
Title
Retention rate
Description
Proportion of participants who complete the intervention
Time Frame
Up to 7 days following recruitment
Title
Intervention fidelity
Description
Percentage of intervention sessions completed
Time Frame
Up to 7 days following recruitment
Secondary Outcome Measure Information:
Title
Incidence of delirium
Description
Incidence of delirium assessed as a positive result on the CAM-ICU
Time Frame
During critical care stay, average of 2 weeks
Title
Duration of delirium
Description
counted at 12-hour periods; the end of delirium is defined when patients are delirium-negative for 24h or discharged to the ward
Time Frame
During critical care stay, average of 2 weeks
Title
Sleep quality
Description
as an average and assessed over time using the Richard Campbell Sleep Questionnaire. This provides a score from 0 - 60, with higher scores representing better quality of sleep
Time Frame
During critical care stay, average of 2 weeks
Title
Mobility level at critical care discharge
Description
Assessed using the Manchester mobility score. Scores range from 1-7 with higher scores representing higher levels of mobility
Time Frame
At ICU discharge, average of 2 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Adults (≥18 years) Admitted to ICU, Able to respond to verbal stimulus (Richmond Agitation Sedation Scale ≥ -3) Expected to stay in the ICU for at least 24 hours. Exclusion Criteria: Death expected within the next 72 hours, Immobility prior to admission, Mobilisation contraindicated (e.g., spinal injury), Delirium diagnosis during this ICU admission, Acute or subacute severe neurological deficit or injury; Severe psychiatric illness (not including depression) or developmental problems; Suspected or confirmed drug or alcohol intoxication/overdose or withdrawal.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
David McWilliams, PhD
Organizational Affiliation
University Hospitals Coventry and Warwickshire NHS Trust
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Hospitals Coventry & Warwickshire
City
Coventry
State/Province
Midlands
ZIP/Postal Code
CV2 2DX
Country
United Kingdom
Facility Name
Oxford University Hospitals NHS Foundation Trust
City
Oxford
Country
United Kingdom

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Mobilisation in the EveNing to TreAt Delirium

We'll reach out to this number within 24 hrs